Another intriguing research pointed out that iron zinc finger protein 36 (ZFP36), a ferroptosis-related gene, was significantly overexpressed in osteosarcoma patients, displaying a negative correlation with progression-free survival and overall survival; targeting ZFP36 could serve as a promising therapeutic biomarker for osteosarcoma patients (Song et al., 2021). Here, ZFP36 is linked to osteosarcoma.